Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 2;5(10):950-956.
doi: 10.1002/bco2.425. eCollection 2024 Oct.

Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery

Affiliations

Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery

Kodai Sato et al. BJUI Compass. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.

Abstract

Objectives: Renal cell carcinoma (RCC) is shown to have a tendency for late recurrence, occurring 5 or more years after curative surgery. Imaging diagnosis is required for follow-up, and there is no definitive answer as to how long this should continue. Some patients discontinue follow-up visits at their own discretion. How best to predict late recurrence and loss to follow-up (LF) remains unclear.

Patients and methods: This study targeted patients diagnosed with non-metastatic RCC who underwent either radical or partial nephrectomy at Chiba University Hospital between 1988 and 2021. Follow-up for patients with RCC is typically lifelong. We used random survival forests (RSFs), a machine learning-based survival analysis method, to predict late recurrence and LF. For verification of prediction accuracy, we applied the time-dependent area under the receiver operating characteristic curve (t-AUC). To analyse the risks of late recurrence and LF, SurvSHAP(t) and partial dependence plots were used.

Results: We analysed 1051 cases in this study. Median follow-up was 58.5 (range: 0-376) months. The predictive accuracy of recurrence using RSF was t-AUC 0.806, 0.761, 0.674 and 0.566 at 60, 120, 180 and 240 months postoperatively, respectively. The recurrence risk impact showed a time-dependent increase up to approximately 50 months postoperatively. Beyond 50 months, there were no distinct risk factors characteristic of late recurrence. The predictive accuracy of LF using RSF was t-AUC 0.542, 0.699, 0.685, 0.628 and 0.674 at 60, 120, 180, 240 and 300 months postoperatively, respectively. The risk of LF increased with advancing age beyond 70 years.

Conclusion: It is difficult to identify factors that predict late recurrence. For long-term follow-up observation, it is essential to pay particular attention to patients with RCC aged 70 years and above. Establishing frameworks to facilitate collaboration with local hospitals near patients' residences and providing care within the community is necessary.

Keywords: late recurrence; loss to follow‐up; machine learning; random survival forests; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

All authors declare that there are no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Predicting late recurrence using machine learning. (A) Verification of prediction accuracy using the time‐dependent area under the receiver operating characteristic curve (t‐AUC). (B) Factor analysis according to time course using SurvSHAP(t). (C) Partial dependence plot for leading risk factors.
FIGURE 2
FIGURE 2
Predicting loss to follow‐up using machine learning. (A) Verification of prediction accuracy using the time‐dependent area under the receiver operating characteristic curve (t‐AUC). (B) Factor analysis according to time course using SurvSHAP(t). (C) Partial dependence plot for leading risk factors.

References

    1. Global cancer statistics 2022: the trends projection analysis. Chem Biol Lett. 2023;10(1):451. PMID: [cited 2024 Mar. 26] Availablefrom: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451
    1. Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87. 10.14740/wjon1279 - DOI - PMC - PubMed
    1. Burgess NA, Koo BC, Calvert RC, Hindmarsh A, Donaldson PJ, Rhodes M. Randomized trial of laparoscopic v open nephrectomy. J Endourol. 2007;21(6):610–613. 10.1089/end.2006.0277 - DOI - PubMed
    1. Kim DK, Kim LH, Raheem AA, Shin TY, Alabdulaali I, Yoon YE, et al. Comparison of trifecta and pentafecta outcomes between T1a and T1b renal masses following robot‐assisted partial nephrectomy (RAPN) with minimum one year follow up: can RAPN for T1b renal masses be feasible? PLoS ONE. 2016;11(3):e0151738. 10.1371/journal.pone.0151738 - DOI - PMC - PubMed
    1. Dabestani S, Marconi L, Kuusk T, Bex A. Follow‐up after curative treatment of localised renal cell carcinoma. World J Urol. 2018;36(12):1953–1959. 10.1007/s00345-018-2338-z - DOI - PubMed

LinkOut - more resources